|
|
 |
 |
Search Results for: B |
 |
|
 |
|
|
 |
| 16 |
Busulfan
Busulfan is a chemotherapy drug that is a cell cycle non-specific alkylating agent which slows the growth of cancer cells. More specifically it belongs to a subclass of alkylating agents known as alkyl sulfonates. Manus Aktteva offers Busulfan, EP, B....
View Detail
| List of Intermediates
|
 |
|
|
| 17 |
[1,1'-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-1-octenyl]-2H-cyclopenta[b]furan-5-yl ester
Manus Aktteva offers Dinoprostone Intermediate, [1,1'-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-1-octenyl]-2H-cyclopenta[b]furan-5-yl ester, 31753-00-1, with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 18 |
[1,1'-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester
Manus Aktteva offers Intermediates of Travoprost, 54142-64-2, [1,1'-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester, for your requirements of RND,....
View Detail
|
 |
|
|
| 19 |
[1,1'-Biphenyl]-4-carboxylic acid [3aR-[3aa,4a(E),5b,6aa]]-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester
Manus Aktteva offers 118583-35-0, Intermediate of Lubiprostone, [1,1'-Biphenyl]-4-carboxylic acid [3aR-[3aa,4a(E),5b,6aa]]-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester, for your evaluation, pilots and commercial re....
View Detail
|
 |
|
|
| 20 |
[1,1'-Biphenyl]-4-carboxylic acid [3aR-[3aa,4a(E),5b,6aa]]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester
Manus Aktteva offers [1,1'-Biphenyl]-4-carboxylic acid [3aR-[3aa,4a(E),5b,6aa]]-4-[4-(3-chlorophenoxy)-3-oxo-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester, Intermediate of Cloprostenol Sodium, having cas no 54324-79-7, with supportive te....
View Detail
|
 |
|
|
| 21 |
[1,1'-Biphenyl]-4-carboxylic acid hexahydro-2-oxo-4-[3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester
Manus Aktteva offers 122921-57-7, Travoprost ester Intermediate, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates
View Detail
|
 |
|
|
| 22 |
[3-(2-benzyloxy-5-bromophenyl)-3-phenylpropyl]-Diisopropylamine(Racemic)
Manus Aktteva offers Racemic Fesoterodine Intermediate, for synthesizing Fesoterodine, for your requirements along with supportive technical package required for evaluation for intermediates
View Detail
|
 |
|
|
| 23 |
1,4-Bis(diphenylphosphino)butane-palladium(II) chloride
Manus Aktteva offers 1,4-Bis(diphenylphosphino)butane-palladium(II) chloride, 29964-62-3 for your requirements of RND, evaluation, along with supportive technical package required for evaluation for intermediate
View Detail
|
 |
|
|
| 24 |
1-Bromoadamantane
Manus Aktteva offers Saxagliptin Intermediate,768-90-1, 1-Bromoadamantane,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 25 |
2,2'-(5-Bromomethyl-1,3-phenylene)-di(2-Methylpropionitrile)
Manus Aktteva offers Anastrozole Intermediate, 120511-84-4, 2,2'-(5-Bromomethyl-1,3-phenylene)-di(2-Methylpropionitrile), for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 26 |
2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid
Manus Aktteva offers 35480-52-5, Flecainide intermediate, 2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 27 |
2-(4-{[2-Butyl-4-chloro-5-(hydroxymethyl)imidazolyl]methyl} phenyl)benzene carbonitrile
Manus Aktteva offers 114772-55-3, Intermediate of Losartan, 2-(4-{[2-Butyl-4-chloro-5-(hydroxymethyl)imidazolyl]methyl} phenyl)benzene carbonitrile,for your requirements of RND, evaluation, pilots and commercial along with supportive technical packag....
View Detail
|
 |
|
|
| 28 |
2-Benzylpyridine
Manus Aktteva offers101-82-6, 2-Benzylpyridine, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 29 |
2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone
Manus Aktteva offers 204205-33-4,2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone, which is one of the Prasugrel intermediates, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 30 |
2-Bromo-3-methylpyridine
Manus Aktteva offers 2-Bromo-3-methylpyridine,3430-17-9,for your requirements of evaluation, pilots and commercials.
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|